Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Leki | Leki |
| Evidence strength | Moderate evidence | Strong evidence |
| Evidence Score | 3/5 | 5/5 |
| User rating | 4.3 (58) | 4.5 (168) |
| Typical dose | In approved indications: usually 200 mg once daily in the morning (narcolepsy, sleep apnea) or about an hour before a night shift begins (shift-work disorder) — by prescription and under medical supervision only | Topical form: 1 ml of 5% solution or the equivalent foam dose, applied twice daily to dry scalp (women sometimes use 5% foam once daily or a 2% solution). Oral form (LDOM, off-label): typically 0.625-5 mg/day, most often 1.25-2.5 mg, individually dosed by a physician |
| Form | Oral tablets | Topical solution or foam; tablets split for the oral form (compounding pharmacy preparation) |
| Average price | Lek na receptę — cena i refundacja zależą od wskazania, zwykle 60–150 zł za opakowanie bez refundacji | 35-90 zł za opakowanie formy miejscowej starczające na miesiąc stosowania (cena zależy od koncentracji, formy i producenta — generyki są tańsze niż marki oryginalne) |
| Monthly cost | ok. 60–150 zł/miesiąc przy codziennym stosowaniu bez refundacji | ok. 35-90 zł/miesiąc dla formy miejscowej; forma doustna (receptura) zwykle wychodzi wyraźnie taniej, ale wymaga recepty i wizyty lekarskiej |
| Time to effects | The wake-promoting effect usually appears within 1–2 hours of taking a dose and lasts most of the day due to its long half-life (about 12–15 hours). | The temporary shedding phase can appear as early as weeks 2-8 of treatment. The first visible signs of regrowth usually appear after 3-4 months of consistent use, with a fully assessable clinical effect after 6-12 months of uninterrupted treatment. The effect requires indefinite continuation; it fades within a few months of stopping. |
| Who it's for | Patients with a confirmed narcolepsy diagnosis, qualified by a neurologist or sleep medicine specialist | Men with early- to moderate-stage androgenetic alopecia, especially in the crown area (less effective where follicles are already completely lost in advanced frontal balding) |